BIAF vs. GH: Which Cancer Detection Stock Is the Better Buy Now?
The cancer diagnostics industry is evolving rapidly as advances in biotechnology, data analytics and precision medicine continue to reshape how diseases are detected and managed. Within this landscape, bioAffinity Technologies, Inc. BIAF and Guardant Health, Inc. GH represent two distinct approaches to cancer diagnostics and molecular testing. While both companies operate in the broader oncology ...












